172
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Computational pharmacology profiling of borapetoside C against melanoma

ORCID Icon, ORCID Icon, , ORCID Icon, , , & show all
Pages 3233-3248 | Received 25 Jan 2023, Accepted 04 May 2023, Published online: 19 May 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nandan Sarkar, Pukar Khanal, Ravi Rawat, Yadu Nandan Dey & Kuldeep K. Roy. Rosmarinic acid and its derivative’s duel as antitubercular agents: insights from computational prediction to functional response in vitro. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-10.
Read now

Articles from other publishers (4)

Akshay Galagali, Vishal S. Patil, Kashinath Hiremath, Ganesh H. Sampat, Rajlaxmi Patil, Rajashri Virge, Darasaguppe R. Harish, Harsha V. Hedge & Subarna Roy. (2024) Investigation of alpha amylase inhibitors from Bidens pilosa L. by in silico and in vitro studies. In Silico Pharmacology 12:1.
Crossref
Kunal Bhattacharya, Bhargab Chandra Nath, Ekbal Ahmed, Pukar Khanal, Nongmaithem Randhoni Chanu, Satyendra Deka, Dibyajyoti Das & Amit Kumar Shrivastava. (2024) Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer . RSC Advances 14:6, pages 4188-4200.
Crossref
Rajashekar S. Chavan, Nayeem A. Khatib, M.G. Hariprasad, Vishal S. Patil & Moqbel Ali Moqbel Redhwan. (2024) Synergistic effects of Momordica charantia, Nigella sativa, and Anethum graveolens on metabolic syndrome targets: In vitro enzyme inhibition and in silico analyses. Heliyon 10:2, pages e24907.
Crossref
Pukar Khanal, Vishal S. Patil, B.M. Patil, Kunal Bhattacharya, Amit Kumar Shrivastava, Raushan K. Chaudhary, Lokjan Singh, Prarambh SR Dwivedi, Darasaguppe R. Harish & Subarna Roy. (2023) The marijuana-schizophrenia multifaceted nexus: Connections and conundrums towards neurophysiology. Computational Biology and Chemistry 107, pages 107957.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.